Born in Guangdong in 1962, Xu Hang was admitted to the Department of Computer Science at Tsinghua University in 1979.
He graduated from the Department of Computer Science of Tsinghua University in 1979, and then transferred to the Department of Electrical Engineering in 1984 to study for a master's degree in biomedical engineering.
1987-1991, he worked for Shenzhen Anke Medical Instrument Company. He led the development of China's first color B-mode ultrasound diagnostic instrument, which won the second prize of the National Science and Technology Progress Award
In 1991, he participated in the founding of Shenzhen Myriad Corporation, and served as the Chairman of the Board of Directors and the Co-Chief Executive Officer.
In 2002, he received an EMBA degree from China Europe International Business School (CEIBS).
The 2005 Shenzhen Mayor's Award recipient, Xu Hang recalls his student days: "My father said I could only choose one of Tsinghua, Peking University and the University of Science and Technology of China. After I set my goal, I had to study day and night." He added that his body had become weak because of his studies, and that he had to wear very thick clothes after the exams when it was summer in Guangzhou.
"The first lesson I learned in life was goal management." Xu Hang summarized. Xu Hang went to Beijing once in his junior year and was impressed by Tiananmen Square, the Forbidden City and the Yuanmingyuan. "I have too much affection for Beijing, and I admire her to the core!" Xu Hang does not hide his love for Beijing. It was this love that made him give up the steady hand of the University of Science and Technology of China and fill in the Tsinghua University. He said: "Tsinghua is a bit risky. Some things are already in your hands, but they are not what you want, and don't ask for them." After 20 years of development, Myriad has become a leader in China's medical device industry. Myriad is China's leading developer and manufacturer of high-tech medical devices and one of the world's leaders in medical device innovation. Since its establishment in 1991, Micrel has been committed to the development and manufacture of clinical medical equipment, covering four major areas: life information and support, clinical testing and reagents, digital ultrasound, and radiology imaging, and has brought medical electronic products with a perfect balance of performance and price to every corner of the world. Today, Myriad's global sales have expanded to more than 190 countries and regions.
Myri is headquartered in Shenzhen, China, with R&D centers in Shenzhen, Beijing, Nanjing, Seattle, New Jersey, and Stockholm, Sweden, as well as branch offices in 29 major cities in China and overseas subsidiaries in the U.S., Canada, the U.K., the Netherlands, Germany, France, Italy, Russia, Turkey, India, Indonesia, Mexico, and Brazil, forming a strong distribution and service presence around the world. The company has formed a strong distribution and service network all over the world. As of December 2009, there were over 5,800 employees worldwide.
In September 2006, as China's first medical device company, Myriad was successfully listed on the New York Stock Exchange, and in October of the same year, Myriad was approved by the Ministry of Science and Technology to officially establish the "National Engineering and Technology Research Center for Medical Diagnostic Instruments. In May 2008, the company completed the acquisition of Datascope's monitoring business in the U.S. and became the third largest brand in the field of global life information monitoring. Taking the responsibility of leading the development of national medical equipment, Myriad is moving towards the grand goal of becoming a world-class enterprise.
Under Xu Hang's leadership, Micrel was successfully listed on the New York Stock Exchange in September 2006, becoming the first Chinese medical device company to be listed on the New York Stock Exchange. Xu Hang was ranked 70th on Forbes' 2006 list of China's richest people, with a market capitalization of about 20 billion yuan and personal assets of about 2.9 billion yuan.
Mediatech started from the development of monitoring products, and now occupies the largest market share of monitoring products in China, and has achieved a leading position in clinical tests and reagents, digital medical ultrasound imaging, biochemical analyzers and other fields, and has become the current leader of China's medical equipment industry, whose products are mainly exported to Europe, Japan, the United States and other developed countries and regions.